1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
- A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies (
- miR-135a inhibits cancer stem cell-driven medulloblastoma development by directly repressing Arhgef6 expression (
- Social classification occurs at the subgroup level evidence based on a multidimensional scaling study (
- 2013
- Trees, contraction groups, and Moufang sets (
- BET bromodomain protein inhibition is a therapeutic option for medulloblastoma (
- ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours (
- 2012
- On the nature of prejudice: subgroups as mental representation of social categories (
- Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas (
- 2010
- Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma (
- Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification (